FemTech Startups

Bellabeat develops AI-powered wearable devices and a health intelligence platform designed to help women track wellness metrics, understand hormonal cycles, and receive personalized health insights. The company targets women seeking preventive care and longevity optimization through cycle-based data analysis and biometric monitoring.

7 investors

Bloomlife provides a remote patient monitoring platform for high-risk patient populations, offering customizable clinical protocols and smart notifications that help care teams identify patients in need and address potential complications early. It is aimed at clinical care teams seeking greater oversight of at-risk patients.

7 investors

Clue is a menstrual and reproductive health app that lets people track their periods, cycle, ovulation, fertility, and related symptoms, and contributes anonymized data to scientific research with institutions such as Johns Hopkins and the Gates Foundation. The company offers a paid Clue Plus subscription and serves over 12 million users worldwide.

7 investors

Cofertility is a fertility company focused on the family-building journey, offering egg freezing, egg donation matching, and related support services to individuals and families. It provides education, choices, and support around egg retrievals, transfers, and pregnancy.

7 investors

Daye offers at-home gynaecological health services for women, including vaginal health screening, hormone testing with NHS-trained clinician consultations, STI and HPV screening, gut and vaginal microbiome supplements, and period care products. It focuses on women's gynae healthcare through diagnostic testing and related products.

7 investors

Fellow is a high-complexity mail-in semen analysis lab operating in the U.S., offering a clinically validated diagnostic-grade mail-in semen test that accounts for sample degradation over time. It serves urology and fertility clinics and is developing seminal-fluid-based diagnostics, including research into cell-free DNA and prostate cancer biomarkers.

7 investors

Gesynta Pharma develops pharmaceutical treatments for inflammation and pain by selectively inhibiting the enzyme mPGES-1. Its lead candidate vipoglanstat is in phase 2 clinical trials as a non-hormonal, non-opioid treatment for endometriosis, alongside a second candidate GS-073 for chronic inflammatory pain.

7 investors

Nurx provides accessible and affordable medications and tests through a digital health platform designed for everyone.

7 investors

Osteoboost develops an FDA-cleared bone health device to treat osteopenia in postmenopausal women. The company builds a wearable medical device grounded in clinical research to help maintain bone density and reduce fracture risk.

7 investors

Qunomedical helps patients find and access fertility treatments such as in vitro fertilization, matching them with reproductive medicine doctors and assigning a personal Patient Manager to guide them from planning through post-treatment. It focuses on affordability and information for people seeking reproductive medicine care.

7 investors

Visby Medical manufactures at-home PCR tests for sexually transmitted infections, providing FDA-authorized results in 30 minutes. The company serves individuals seeking fast, private STI testing without clinical delays, with integrated telehealth access for positive results.

7 investors

Vivoo develops at-home urine testing products with machine learning-powered image processing to help users monitor their hydration, nutrition, and overall wellness. The company serves individuals seeking personalized health insights and partners with healthcare professionals to deliver science-backed health monitoring solutions.

7 investors

Womaness makes Melt For You, hormone-free vaginal inserts that melt at body temperature to release medical-grade hyaluronic acid, marketed to women experiencing vaginal dryness, irritation, or discomfort during intimacy. The applicator-free suppositories are a consumer wellness product in the menopause and women's intimate health category.

7 investors

Gaia offers fixed-price IVF and fertility treatment plans in the U.S., bundling costs into one price with monthly payment options, unlimited embryo transfers, and guaranteed minimum egg counts. It partners with a network of over 180 fertility clinics and provides members with support from nurses, therapists, nutritionists, and advocates, serving hopeful parents, single parents, LGBTQIA+ families, and people freezing eggs.

6 investors

Health In Her Hue is a digital health platform for women of color that connects users with culturally responsive healthcare providers and offers a library of culturally tailored health content, community support, and peer-based Care Squad groups. It focuses on health and wellness needs specific to women of color, including reproductive health.

6 investors

Joylux develops a line of consumer products focused on women's intimate and pelvic floor health, created with input from an Ob-Gyn to address changes women experience post-delivery and with age. The company targets women seeking solutions for intimate wellness.

6 investors

A nonprofit organization that provides funding to community-based organizations globally to increase access to period care products and menstrual health education.

6 investors

Ovia Health provides digital health tools and clinical programs for reproductive and family health, including fertility, pregnancy, and parenthood support. The platform delivers personalized coaching, health pathways, and risk identification to help families across their health journey.

6 investors

Persephone Biosciences develops a synbiotic (probiotic and prebiotic combination) supplement for infants designed to replenish key beneficial gut bacteria. The product targets parents seeking to support their babies' digestive health, immune development, and overall microbiome health.

6 investors

Raydiant Oximetry is a clinical-stage medical device company developing Lumerah, a noninvasive fetal pulse oximeter that directly measures fetal oxygen levels using biophotonics and machine learning. The device is intended to give obstetrical providers a more accurate tool for evaluating fetal oxygenation during labor and delivery.

6 investors

SimpliFed provides a virtual pregnancy, postpartum, and baby feeding care program that connects new families with certified lactation consultants, nurse practitioners, and other maternal health experts. It offers insurance-covered services including lactation support, breast pump prescriptions, mental health screening, and low-risk virtual OB care for expecting and new parents.

6 investors

FlexFits produces menstrual products and advocates for accessible period care. The company serves menstruators globally and works to destigmatize menstrual health.

6 investors

Visana Health is a virtual women's health clinic providing telehealth-based gynecological and reproductive care through a clinical team of women's health specialists across obstetrics, gynecology, midwifery, primary care, and related fields. It treats conditions such as PCOS, endometriosis, menopause, pelvic pain, and offers contraception, family planning, and hormone management for women across their lifespan.

6 investors

YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials. The company targets male contraceptive users seeking alternatives to condoms or vasectomy.

6 investors